{"id":1052,"date":"2026-05-19T16:00:18","date_gmt":"2026-05-19T13:00:18","guid":{"rendered":"https:\/\/life-peptide.com\/?post_type=product&#038;p=1052"},"modified":"2026-05-28T16:55:13","modified_gmt":"2026-05-28T13:55:13","slug":"blend-cagrilintide-5-mg-retatrutide-10-mg","status":"publish","type":"product","link":"https:\/\/life-peptide.com\/de\/product\/blend-cagrilintide-5-mg-retatrutide-10-mg\/","title":{"rendered":"Blend Cagrilintide 5 mg + Retatrutide 10 mg"},"content":{"rendered":"<h4><strong>Multi-pathway metabolic research blend<\/strong><\/h4>\n<p>Cagrilintide \/ Retatrutide is a combination peptide blend investigated for its interaction with complementary metabolic signaling pathways, integrating amylin receptor activity with multi-receptor incretin agonism (GLP-1, GIP, glucagon).<\/p>\n<p>This blend is of particular interest in advanced metabolic research models exploring the combined effects of satiety signaling, energy expenditure modulation, and multi-pathway endocrine interaction. By pairing an amylin analogue with a triple-receptor agonist, this combination enables investigation into broader metabolic regulation frameworks compared to single- or dual-pathway compounds.<\/p>\n<p>Researchers studying complex energy balance systems and multi-hormonal signaling interactions often examine such combinations for their ability to model layered physiological responses. For foundational context, see the GLP-1 metabolic research guide.<\/p>\n<h4><strong>Research applications (investigational)<\/strong><\/h4>\n<p>This combination has been explored in research settings for:<\/p>\n<ul>\n<li>Integrated amylin and incretin receptor signaling<\/li>\n<li>Multi-pathway appetite and satiety regulation models<\/li>\n<li>Energy expenditure and metabolic rate interaction studies<\/li>\n<li>Glucose regulation across combined hormonal pathways<\/li>\n<li>Advanced endocrine system modeling (triple + amylin interaction)<\/li>\n<li>Comparative analysis vs single and dual agonist systems<\/li>\n<\/ul>\n<p>These areas reflect ongoing scientific investigation into complex metabolic signaling rather than established applications.<\/p>\n<h4><strong>Product characteristics<\/strong><\/h4>\n<p>Purity: \u2265 98% (HPLC)<br \/>\nAppearance: white lyophilized powder<br \/>\nComposition: Cagrilintide 5 mg + Retatrutide 10 mg<br \/>\nMolecular formula Cagrilintide \/ Retatrutide: C<sub>194<\/sub>H<sub>312<\/sub>N<sub>54<\/sub>O<sub>59<\/sub> S<sub>2<\/sub> \/ C<sub>221<\/sub>H<sub>342<\/sub>N<sub>46<\/sub>O<sub>68<\/sub><br \/>\nMolecular weight Cagrilintide \/ Retatrutide: 4409.01 \/ 4731.4<br \/>\nSequence Cagrilintide: {diacid-C20-\u03b3-Glu} KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH2<br \/>\nSequence Retatrutide: Y{Aib}QGTFTSDYSI{\u03b1-Me-Leu}LDK-Lys{diacid-C20-\u03b3-Glu-(AEEA)}-AQ{Aib}AFIEYLLEGGPSSGAPPPS-NH2<br \/>\nStorage: store lyophilized powder at -20\u00b0C, protect from light and moisture. Reconstituted solution should be kept at 2\u20138\u00b0C and used within a short period.<\/p>\n<h4><strong>Why choose this blend<\/strong><\/h4>\n<p>Multi-pathway research model (amylin + GLP-1\/GIP\/glucagon)<br \/>\n\u2265 98% purity verified by HPLC.<br \/>\nProduced in GMP-compliant facilities under strict QC protocols.<br \/>\nEach batch carefully lab tested after production (Certificate of Analysis available under product pictures).<br \/>\nFreeze-dried (lyophilized) for maximum stability and extended shelf life.<br \/>\nSealed in sterile vials, ready for reconstitution.<br \/>\nReconstitution: requires careful reconstitution with bacteriostatic water. Peptides in this class may dissolve gradually and should be handled gently to maintain solution clarity.<\/p>\n<h4><strong>Selected research references<\/strong><\/h4>\n<ul>\n<li>Lau J et al. <em>Amylin analogue development and metabolic signaling research. Journal of Medicinal Chemistry<\/em>, 2021.<\/li>\n<li>Jastreboff AM et al. <em>Triple-receptor agonism in metabolic research. New England Journal of Medicine<\/em>, 2023.<\/li>\n<li>Rosenstock J et al. <em>Multi-pathway incretin-based research models. The Lancet<\/em>, 2023.<\/li>\n<li>Knop FK et al. <em>Hormonal synergy in metabolic regulation. Nature Reviews Endocrinology<\/em>, 2023.<\/li>\n<\/ul>\n<h4><strong>Related research context<\/strong><\/h4>\n<p>Cagrilintide \/ Retatrutide represents an advanced multi-pathway research model combining amylin receptor signaling with triple-receptor incretin agonism (GLP-1, GIP, glucagon).<br \/>\nFor structured comparison and deeper context, researchers may also examine:<br \/>\n\u2022 <a href=\"https:\/\/life-peptide.com\/de\/product\/retatrutide-10-mg\/\">Retatrutid<\/a> \u2014 triple-receptor agonist (GLP-1\/GIP\/glucagon)<br \/>\n\u2022 <a href=\"https:\/\/life-peptide.com\/de\/product\/cagrilintide-5-mg\/\">Cagrilintid<\/a> \u2014 amylin analogue (satiety signaling pathway)<br \/>\n\u2022 <a href=\"https:\/\/life-peptide.com\/de\/product\/tirzepatide-10-mg\/\">Tirzepatid<\/a> \u2014 dual incretin agonist (GLP-1\/GIP)<br \/>\n\u2022 <a href=\"https:\/\/life-peptide.com\/de\/product\/semaglutide-10-mg\/\">Semaglutid<\/a> \u2014 GLP-1 receptor agonist<br \/>\nFor broader mechanism comparison, see the <a href=\"\/de\/glp-1-metabolic-research-guide\/\">Leitfaden zur Stoffwechselforschung von GLP-1<\/a> and explore the <a href=\"\/de\/kategorie\/metabolische-forschung-peptide\/\">Metabolic \u0440esearch category<\/a>.<br \/>\nThis blend is most relevant in studies investigating layered hormonal signaling and multi-receptor metabolic interaction frameworks.<\/p>\n<p><strong>NOTE<\/strong>: This is for educational reference only and does not constitute medical advice.<\/p>\n<p><strong>Disclaimer<\/strong><br \/>\nThis product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.<\/p>","protected":false},"excerpt":{"rendered":"<p>Cagrilintide \/ Retatrutide blend combining amylin analogue signaling with triple-receptor incretin pathways in metabolic research models.<\/p>\n<p>||<\/p>\n<p>HPLC Purity \u226598% | Lyophilized | Research grade | EU-based supply | Free EU shipping over \u20ac100<\/p>","protected":false},"featured_media":1051,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[19],"product_tag":[157,152,257,155,247,156,140,246],"class_list":["post-1052","product","type-product","status-publish","has-post-thumbnail","product_cat-metabolic-research-peptides","product_tag-advanced-metabolic-research","product_tag-amylin-analogue","product_tag-appetite-regulation","product_tag-glp-1-gip-glucagon","product_tag-metabolic-peptide","product_tag-multi-receptor-agonist","product_tag-triple-agonist","product_tag-weight-loss-peptide","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product\/1052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/comments?post=1052"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/media\/1051"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/media?parent=1052"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product_brand?post=1052"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product_cat?post=1052"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product_tag?post=1052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}